Baxter International Inc. (BAX)

77.24
NYSE : Health Technology
Prev Close 77.24
Day Low/High 0.00 / 0.00
52 Wk Low/High 60.78 / 77.85
Avg Volume 2.64M
Exchange NYSE
Shares Outstanding 534.27M
Market Cap 41.16B
EPS 1.30
P/E Ratio 46.41
Div & Yield 0.76 (0.90%)

Latest News

Tariffs, Trade, and Now, Turkey: Cramer's 'Mad Money' Recap (Monday 8/13/18)

Tariffs, Trade, and Now, Turkey: Cramer's 'Mad Money' Recap (Monday 8/13/18)

Jim Cramer says investors should turn this Turkey-induced selloff into a buying opportunity.

Baxter Announces CE Mark And Regulatory Approval Of New Evo IQ Infusion System For The United Kingdom, Ireland, Australia And New Zealand

Baxter Announces CE Mark And Regulatory Approval Of New Evo IQ Infusion System For The United Kingdom, Ireland, Australia And New Zealand

Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced the CE marking of the Evo IQ Infusion System.

The Dip in Baxter International Should Soon Be a Buying Opportunity

The Dip in Baxter International Should Soon Be a Buying Opportunity

BAX declined recently to break the rising 50-day moving average line.

Baxter Reports Second-Quarter 2018 Results And Increases Earnings Outlook For Full-Year 2018

Baxter Reports Second-Quarter 2018 Results And Increases Earnings Outlook For Full-Year 2018

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2018 and increased its full-year 2018 earnings guidance.

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.

Baxter To Host Second Quarter 2018 Financial Results Conference Call For Investors

Baxter To Host Second Quarter 2018 Financial Results Conference Call For Investors

Baxter International (NYSE:BAX), will host a conference call to discuss its second quarter 2018 financial results on Thursday, July 26, 2018, at 7:30 a.

Baxter Releases 2017 Corporate Responsibility Report And Reinforces Its Commitment To Enriching Communities Around The World

Baxter Releases 2017 Corporate Responsibility Report And Reinforces Its Commitment To Enriching Communities Around The World

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2017 Corporate Responsibility Report, highlighting its efforts to create lasting social, economic and environmental value in the communities the company...

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits

Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits

When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Baxter Highlights Business Strategies And Innovation At 2018 Investor Conference

Baxter Highlights Business Strategies And Innovation At 2018 Investor Conference

Baxter International Inc. (NYSE:BAX), today at its investor conference, outlined the company's strategies to drive sustained growth, deliver attractive shareholder value and advance patient care around the world.

Baxter To Present At The Goldman Sachs Healthcare Conference

Baxter To Present At The Goldman Sachs Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018 in Rancho Palos Verdes, CA.

Baxter To Host 2018 Investor Conference

Baxter To Host 2018 Investor Conference

Baxter International Inc. (NYSE: BAX) will host an investor conference on Monday, May 21, 2018 in New York City at the Pierre Hotel.

Baxter Announces U.S. FDA Clearance Of New Spectrum IQ Infusion System

Baxter Announces U.S. FDA Clearance Of New Spectrum IQ Infusion System

Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.

Baxter Declares Dividend And Announces Quarterly Dividend Increase

Baxter Declares Dividend And Announces Quarterly Dividend Increase

Baxter International Inc. (NYSE:BAX) today announced an approximately 19% increase in the company's quarterly dividend rate.

Baxter And The International Society Of Nephrology Announce A Collaboration To Address Growing Prevalence Of Kidney Disease

Baxter And The International Society Of Nephrology Announce A Collaboration To Address Growing Prevalence Of Kidney Disease

Baxter International Inc. (NYSE:BAX), a global innovator in renal (kidney) care, and the International Society of Nephrology (ISN) announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly...

Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018

Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018

Baxter International Inc. (NYSE: BAX) today reported results for the first quarter of 2018 and increased its full-year 2018 guidance.

Baxter To Host First Quarter 2018 Financial Results Conference Call For Investors

Baxter To Host First Quarter 2018 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE: BAX), will host a conference call to discuss its first quarter 2018 financial results on Thursday, April 26, 2018, at 7:30 a.

Baxter International Inc. To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. (NYSE:BAX) will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 8, 2018 at 9:00 a.

Baxter Completes Acquisition Of RECOTHROM And PREVELEAK To Broaden Surgical Hemostat And Sealant Portfolio

Baxter Completes Acquisition Of RECOTHROM And PREVELEAK To Broaden Surgical Hemostat And Sealant Portfolio

Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its previously announced acquisition of two hemostat and sealant...

Why Value Investor Benjamin Graham Remains Relevant Today

Why Value Investor Benjamin Graham Remains Relevant Today

I still also use Graham-inspired stock screens, including one based on his 'stocks for the defensive investor' methodology.

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the Barclays Global Healthcare Conference on Tuesday, March 13, 2018, in Miami, Fla.

Baxter To Present At The Raymond James & Associates 39th Annual Institutional Investors Conference

Baxter To Present At The Raymond James & Associates 39th Annual Institutional Investors Conference

Baxter International Inc. (NYSE: BAX) will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla.

Baxter Reports 2017 Fourth-Quarter And Full-Year Results

Baxter Reports 2017 Fourth-Quarter And Full-Year Results

Baxter International Inc. (NYSE:BAX) today reported results for the fourth quarter and full-year ended December 31, 2017, and provided its financial guidance for 2018.

Baxter To Present At The RBC Capital Markets 2018 Global Healthcare Conference

Baxter To Present At The RBC Capital Markets 2018 Global Healthcare Conference

Baxter International Inc. (NYSE: BAX) will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018, in New York.

TheStreet Quant Rating: B+ (Buy)